Assenagon Asset Management S.A. lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 33.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 194,341 shares of the company's stock after selling 97,749 shares during the period. Assenagon Asset Management S.A. owned about 0.12% of Option Care Health worth $6,792,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Option Care Health by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock valued at $448,118,000 after buying an additional 75,313 shares in the last quarter. Wellington Management Group LLP grew its stake in Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after acquiring an additional 8,400,208 shares during the period. Dimensional Fund Advisors LP increased its holdings in Option Care Health by 17.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after acquiring an additional 591,042 shares in the last quarter. Northern Trust Corp raised its position in Option Care Health by 11.8% during the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock worth $60,934,000 after acquiring an additional 278,158 shares during the period. Finally, Norges Bank acquired a new position in Option Care Health during the fourth quarter worth $60,219,000. Institutional investors and hedge funds own 98.05% of the company's stock.
Option Care Health Price Performance
OPCH traded down $0.17 during trading on Wednesday, reaching $31.67. The company's stock had a trading volume of 1,042,728 shares, compared to its average volume of 1,916,212. The company has a market cap of $5.19 billion, a price-to-earnings ratio of 25.55, a PEG ratio of 1.92 and a beta of 0.74. The firm has a fifty day simple moving average of $32.16 and a two-hundred day simple moving average of $30.42. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The company has a quick ratio of 1.02, a current ratio of 1.54 and a debt-to-equity ratio of 0.82.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The business's revenue for the quarter was up 16.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.26 earnings per share. As a group, analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.
Wall Street Analysts Forecast Growth
OPCH has been the subject of a number of research reports. JPMorgan Chase & Co. boosted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Barrington Research reiterated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a report on Wednesday, April 30th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, JMP Securities restated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research report on Wednesday. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, Option Care Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.
Get Our Latest Stock Report on Option Care Health
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
